TY  - JOUR
AU  - Navarrete, Carmen
AU  - Garcia-Martin, Adela
AU  - Garrido-Rodriguez, Martin
AU  - Mestre, Leyre
AU  - Feliu, Ana
AU  - Guaza, Carmen
AU  - Calzado, Marco A
AU  - Muñoz, Eduardo
PY  - 2020
DO  - 10.1016/j.nbd.2020.104994
UR  - http://hdl.handle.net/10668/15843
T2  - Neurobiology of disease
AB  - Multiple Sclerosis (MS) is characterized by a combination of inflammatory and neurodegenerative processes in the spinal cord and the brain. Natural and synthetic cannabinoids such as VCE-004.8 have been studied in preclinical models of MS and...
LA  - en
PB  - Elsevier
KW  - EHP-101
KW  - Inflammation
KW  - Multiple sclerosis
KW  - Remyelination
KW  - Transcriptomic
KW  - Animals
KW  - Cannabinoid receptor agonists
KW  - Cannabinoids
KW  - Chelating agents
KW  - Cuprizone
KW  - Demyelinating diseases
KW  - Disease models, animal
KW  - Encephalomyelitis, autoimmune, experimental
KW  - Inflammation
KW  - Mice
KW  - Mice, inbred C57BL
KW  - Multiple sclerosis
KW  - Remyelination
KW  - Spinal cord
TI  - Effects of EHP-101 on inflammation and remyelination in murine models of Multiple sclerosis.
TY  - research article
VL  - 143
ER  -